Axa S.A. Biomarin Pharmaceutical Inc Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Axa S.A. holds 562,664 shares of BMRN stock, worth $37.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

562,664

Previous 573,071 1.82%

Holding current value

$37.3 Million

Previous $47.2 Million 16.17%

% of portfolio

0.12%

Previous 0.14%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $718,291 - $976,592	-10,407 Reduced 1.82%	562,664 $39.5 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $12.6 Million - $15.6 Million	168,620 Added 41.69%	573,071 $47.2 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $4.09 Million - $4.83 Million	48,759 Added 13.71%	404,451 $35.3 Million
Q4 2023 Jul 16, 2024	SELL	$76.22 - $98.51 $3.72 Million - $4.8 Million	-48,759 Reduced 12.06%	355,692 $34.3 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $583,540 - $754,192	-7,656 Reduced 2.11%	355,692 $34.3 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $1.95 Million - $2.17 Million	-22,937 Reduced 5.94%	363,348 $32.1 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $113,464 - $131,292	1,309 Added 0.34%	386,285 $33.5 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $1.95 Million - $2.61 Million	-22,253 Reduced 5.46%	384,976 $37.4 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $13.3 Million - $17.9 Million	-164,367 Reduced 28.76%	407,229 $42.1 Million
Q3 2022 Feb 14, 2023	SELL	$82.16 - $96.94 $3.81 Million - $4.5 Million	-46,391 Reduced 7.51%	571,596 $48.5 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $3.81 Million - $4.5 Million	-46,391 Reduced 7.51%	571,596 $48.5 Million
Q2 2022 Feb 14, 2023	BUY	$71.48 - $86.85 $13.5 Million - $16.4 Million	189,380 Added 44.18%	617,987 $51.2 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $13.5 Million - $16.4 Million	189,380 Added 44.18%	617,987 $51.2 Million
Q1 2022 Feb 14, 2023	SELL	$74.28 - $92.69 $10.6 Million - $13.3 Million	-142,989 Reduced 25.02%	428,607 $33 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $222,171 - $277,235	-2,991 Reduced 0.69%	428,607 $33 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2.28 Million - $2.91 Million	31,841 Added 7.97%	431,598 $38.1 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $8.67 Million - $9.91 Million	115,951 Added 40.86%	399,757 $30.9 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $3.04 Million - $3.42 Million	-40,293 Reduced 12.43%	283,806 $23.7 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $3.87 Million - $4.7 Million	-51,794 Reduced 13.78%	324,099 $24.5 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $790,795 - $982,368	10,891 Added 2.98%	375,893 $33 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $5.82 Million - $10.6 Million	-81,035 Reduced 18.17%	365,002 $27.8 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $10.9 Million - $17 Million	136,717 Added 44.2%	446,037 $55 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $5.14 Million - $6.98 Million	-72,046 Reduced 18.89%	309,320 $26.1 Million
Q4 2019 Feb 18, 2020	SELL	$64.27 - $86.37 $377,779 - $507,682	-5,878 Reduced 1.52%	381,366 $32.2 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $3.46 Million - $4.37 Million	51,384 Added 15.3%	387,244 $26.1 Million
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $275,841 - $322,358	3,433 Added 1.03%	335,860 $28.8 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $2.76 Million - $3.23 Million	-32,750 Reduced 8.97%	332,427 $29.5 Million
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $8,174 - $10,819	-102 Reduced 0.03%	365,177 $31.1 Million
Q3 2018 Nov 08, 2018	SELL	$93.92 - $105.72 $4.88 Million - $5.49 Million	-51,962 Reduced 12.45%	365,279 $35.4 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $2.8 Million - $3.65 Million	36,840 Added 9.68%	417,241 $39.3 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $328,854 - $392,195	-4,234 Reduced 1.1%	380,401 $30.8 Million
Q4 2017 Feb 13, 2018	SELL	$80.76 - $95.13 $18,655 - $21,975	-231 Reduced 0.06%	384,635 $34.3 Million
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $31 Million - $36.5 Million	384,866	384,866 $35.8 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account